The grade of neoangiogenesis and the bone marrow blast count predict leukemic transformation-free survival in myelodysplastic syndromes

• Emőke Horváth,
• Csilla Finna,
• Smaranda Demian,
• Előd-Ernő Nagy

Affiliations

Emőke Horváth

Department of Pathology, University of Medicine and Pharmacy, Târgu-Mures, Romania

Csilla Finna

Department of Pathology, University of Medicine and Pharmacy, Târgu-Mures, Romania

Smaranda Demian

University of Medicine and Pharmacy, Hematology Clinic 1, Emergency Clinical Hospital, Târgu-Mures, Romania

Előd-Ernő Nagy

Department of Pharmaceutical Biochemistry, University of Medicine and Pharmacy, Târgu-Mures, Romania